In vitro studies on controlled‐release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam
- 19 November 2004
- journal article
- Published by Wiley in Journal of Clinical Periodontology
- Vol. 31 (12) , 1117-1121
Abstract
Background: Delivery of medications into periodontal pockets to suppress or eradicate the pathogenic microbiota or modulate the inflammatory response, thereby limiting periodontal tissue destruction, has attracted significant interest with the purpose of effective periodontal treatment. However, no study has previously attempted to develop a controlled‐release formulation of anti‐inflammatory agents to be used in the field of periodontology. The aim of the present study was to examine the in vitro release profile of chlorhexidine gluconate, indomethacin, and meloxicam from cellulose acetate films.Methods: Cellulose acetate films containing chlorhexidine gluconate, indomethacin, and meloxicam were prepared and cut in a form to fit to the periodontal pocket anatomy. The release of active agents was studied in 10 ml artificial saliva at 37°C. Apparatus Vibrax was used at 150 r.p.m. Determinations were carried out spectrophotometrically and the release profiles were plotted as a function of time.Results: The formulations showed two different release patterns for a total observation period of approximately 120 h. When the formulations of the three active agents were compared, the release patterns of meloxicam and chlorhexidine gluconate were found to be similar, while the indomethacin‐containing formulation exhibited the fastest release rate.Conclusions: As a conclusion, cellulose acetate may be a suitable inert material for obtaining a prolonged local release of various anti‐inflammatory agents like meloxicam. Further in vitro and in vivo studies are required before starting clinical applications of these controlled‐release formulations of anti‐inflammatory agents.Keywords
This publication has 29 references indexed in Scilit:
- Gingival Crevicular Fluid Matrix Metalloproteinase‐8 Levels Following Adjunctive Use of Meloxicam and Initial Phase of Periodontal TherapyJournal of Periodontology, 2002
- Local delivery of chlorhexidine gluconate (PerioChipTM) in periodontal maintenance patientsJournal of Clinical Periodontology, 2001
- Selective Cyclooxygenase‐2 Inhibition Prevents Alveolar Bone Loss in Experimental Periodontitis in RatsJournal of Periodontology, 2000
- Development of a Classification System for Periodontal Diseases and ConditionsAnnals of Periodontology, 1999
- Pharmacology of Meloxicam, A New Non-Steroidal Anti-Inflammatory Drug with an Improved Safety Profile Through Preferential Inhibition of COX-2Rheumatology, 1996
- Salivary PAF Levels Correlate with the Severity of Periodontal InflammationJournal of Dental Research, 1995
- Microbial etiological agents of destructive periodontal diseasesPeriodontology 2000, 1994
- Combined antibiotic (metronidazole) and mechanical treatment effects on the subgingival bacterial flora of sites with recurrent periodontal diseaseJournal of Clinical Periodontology, 1988
- Monolithic Tetracycline‐containing Fibers for Controlled Delivery to Periodontal PocketsJournal of Periodontology, 1983
- The Development and in Vitro Evaluation of Acrylic Strips and Dialysis Tubing for Local Drug DeliveryJournal of Periodontology, 1982